Martin Hirst

Researcher
  • Canada's Michael Smith Genome Sciences Centre
  • University of British Columbia
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Rare Cancers

    New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

    A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...

    Read More
  • Blood Cancers

    Exploiting pathogenic mechanisms in acute leukemia for clinical translation

    A longstanding Terry Fox-funded project on hard-to-treat leukemias has been renewed, and the new injection of funds – $6.3 million over five years – will help to furthe...

    Read More
  • Completed
    Blood Cancers

    Epigenetic basis of acute myeloid leukemia

    Vitamin C may be best known for its role in preventing the common cold, but Dr. Martin Hirst’s research suggests it may also reverse abnormal and potentially cancer causing changes to the epigen...

    Read More
  • Completed
    Rare Cancers

    Genomics of forme fruste tumours: new vistas on cancer biology and treatment

    Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...

    Read More
  • Completed
    Blood Cancers

    Core pathogenic pathways in human leukemia

    Treatment for acute myeloid leukemia (AML), one of the most aggressive forms of leukemia, involves chemotherapy drugs that many patients find difficult to tolerate and long-term survival is low. New t...

    Read More

Related News & Events

  • Research Highlight|January 09, 2020

    Newly created synthetic cancer cells help advance understanding of leukemias

    For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...

  • In the Media|September 11, 2015

    FOX 35: Vitamin C crucial part of cancer breakthrough – funded by Fox

    Could Vitamin C restore the balance to the epigenome in the blood cancer and become a therapeutic benefit to help those in need?

  • Press Release|August 19, 2015

    TFRI BC researchers aim to improve treatment, diagnostics for leukemia and lymphoma

    Vancouver, BC --Terry Fox’s research legacy continues in British Columbia 35 years after he set out on his Marathon of Hope. Two local cancer research...

  • All News & Events